iiinova — where your digital self keeps evolving

Reposted by Dr Nicholas Brittain

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 3h

Remembering Ruby #LiveKindly,LiveLoudly This week the LEGEND group took some time out in memory of Ruby, on what would have been her 25th Birthday to share some chocolate cake. We are immensely grateful for support from Ruby's Fund, and aim to continue her legacy through our work❤️

The LEGEND group, sharing chocolate cake in memory of Ruby on what would have been her 25th Birthday.

011

Reposted by Dr Nicholas Brittain

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 06/10/2026

🧬 Research Technician Opportunity 🧬 Looking to contribute to cutting-edge paediatric leukaemia research funded by @cancerresearchuk.org using advanced epigenomics and CRISPR methods? The LEGEND group is hiring, join the team! 🔬 Full details in the link 👇 bit.ly/3VOQipJ%E2%8...

The LEGEND group in the lab, at the Wolfson Childhood Cancer Research Centre, Newcastle University.

035

Reposted by Dr Nicholas Brittain

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 02/10/2026

Last month, @letimarchetti.bsky.social gave an introduction to our research to the team at Leica Biosystems. It was a great opportunity to share our work, discuss our research, and exchange ideas. Thank you to Leica and @childcancernth.bsky.social for the invitation and the engaging discussions!

033

Reposted by Dr Nicholas Brittain

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 24/09/2026

On #WorldCancerResearchDay, the group embraced #gold to support @childcancernth.bsky.social initiative #PaintTheToonGold to raise awareness for #ChildhoodCancerAwarenessMonth. Our efforts go beyond the lab when it comes to support #CancerResearch 🧬🧡

036

Reposted by Dr Nicholas Brittain

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 18/09/2026

This Blood Cancer Awareness Month, we stand alongside patients, families, clinicians and researchers working towards a future where blood cancers are detected earlier, treated and ultimately prevented. Every discovery starts with research at the bench 🧪🩸 #BloodCancerAwarenessMonth

Thank you to Martin Newman for capturing our research in the lab.

044

Reposted by Dr Nicholas Brittain

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 11/09/2026

We’re glad to have participated in the 23rd CLR-UK Annual Meeting in Nottingham! It was a great opportunity to share our research, contribute to organising the meeting, exchange ideas, and network with fellow scientists working in childhood leukaemia research. #CLRUK2026 #BCUK

033

Reposted by Dr Nicholas Brittain

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 04/09/2026

A multicultural lab group comes with so many advantages! We don’t only share valuable ideas and different prospective, but we also get to share traditional food and learn about each other's cultures. Thanks @alsayadi.bsky.social for introducing us to Arabic coffee and sharing sweet treats!

Arabic coffee, dates and traditional sweet treats.

055

Reposted by Dr Nicholas Brittain

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 31/07/2026

This week @dr-ahlamq.bsky.social has been preparing DNA for long-read sequencing. Historically, DNA is broken into 'chunks' to read the code. Long-read sequencing is newer technology for deciphering much longer stretches of DNA, providing in-depth information about leukaemia genetics.

Dr Ahlam Alqahtani is carefully examining a tube containing DNA that has been extracted for long-read sequencing technologies.

The long strands of DNA 'wrap-around' glass beads within the tube, enabling us to extract much longer DNA strands than traditional methods.

053

Dr Nicholas Brittain @drnickbrittain.bsky.social · 27/07/2026

We really enjoyed hosting Lucy and Kunwoo. Two very talented students that I am sure will make a great impact wherever their careers take them next.

010

Reposted by Dr Nicholas Brittain

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 04/06/2026

@letimarchetti.bsky.social represented the LEGEND group at the 'Young Researchers Chromatin Club' seminar series by @activemotifusa.bsky.social Leti presented exciting research progress, using multiple chromatin profiling methods to understand genetic regulation in leukaemia.

A picture of Leti's online Young Researchers Chromatin Club seminar on Zoom, viewed by a laptop of a LEGEND group member.

052

Reposted by Dr Nicholas Brittain

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 05/05/2026

🧬 Fighting Paediatric Leukaemia with Epigenetics: 4-Year PhD Opportunity! Looking to push the boundaries of cancer research using cutting-edge epigenomic technology? We are seeking a dedicated PhD student to join the LEGEND group. Full details in the link below: bit.ly/LEGEND_PhD

The LEGEND group in the lab.
From left to right: Dr Ahlam Alqahtani, Dr Nicholas Brittain, Dr Letizia Marchetti, Camille Drai, Dr Lisa Russell (group leader), Ahmed Alsayadi, Phoebe Snow

134

Reposted by Dr Nicholas Brittain

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 30/03/2026

Last week was an exciting one for the LEGEND Group! We attended NUBI Live, where Lisa and Phoebe gave talks, and Ahmed and Leti presented posters. Nick also presented in the @nucancer.bsky.social PMGI Symposium. Excellent science with plenty of engaging discussions!

062

Reposted by Dr Nicholas Brittain

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 21/03/2026

Very proud that LEGEND Group technician, Camille Drai, won two prestigious Techncian Awards. Well done @camilledrai.bsky.social 👏

072